封面
市場調查報告書
商品編碼
1922657

日本介入性心臟病器材市場報告:按產品、最終用戶和地區分類(2026-2034 年)

Japan Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年,日本介入性心臟病器材市場規模達11.9億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到24.2億美元,2026年至2034年的複合年成長率為8.22%。心臟病患病率上升、醫療技術的最新進展、扶持政策的訂定以及微創手術(MI)相對於傳統手術的日益普及,都是推動市場成長的關鍵因素。

介入性心臟病學器械是指用於經導管治療結構性心臟疾病的各種專用儀器和設備。這些器械包括支架、導管、導管導引線、球囊和血管閉合裝置。介入性心臟病學器材具有微創、精準、柔軟性及先進技術整合等諸多特點。它們可用於多種手術,包括血管成形術、置入術、瓣環成形、先天性心臟疾病矯正術、經皮瓣膜修復術和冠狀動脈血栓切除術。介入性心臟病學器械有助於改善患者預後、縮短恢復時間、降低感染風險、減少住院時間、減輕術中不適並提高診斷準確性。此外,它們還以其長期成本效益、低手術風險、高成功率以及能夠滿足不適合開胸手術的高風險患者的需求而聞名。

日本介入性心臟病器材市場趨勢:

老年人中心臟病盛行率的上升,導致對包括介入治療在內的先進心臟治療的需求不斷成長,從而推動了市場成長。此外,高血壓、肥胖和糖尿病等文明病的增加,也增加了心血管疾病的風險,進一步促進了市場成長。醫療技術的進步催生了先進且有效的介入性心臟病器械,對市場成長產生了積極影響。此外,政府的支持性政策和對醫療基礎設施的投資也推動了市場成長。由於經經皮冠狀動脈介入治療(PCI)恢復時間較短、風險較低,其相對於傳統手術的日益普及也是市場成長的促進因素。此外,醫療費用支出不斷成長以及先進醫療程序的保險覆蓋範圍擴大,也是市場成長的重要促進因素。能夠進行介入性心臟病治療的專家和醫療機構數量的增加,也對市場成長產生了正面影響。同時,全球和日本主要醫療設備公司之間在技術轉移和產品開發方面日益增多的合作與夥伴關係,也推動了市場成長。此外,日本大眾對心血管疾病及其治療方法的認知不斷提高,也是推動市場成長的因素之一。此外,旨在提高介入性心臟病器材療效和安全性的持續研究和臨床試驗正在推動市場成長。同時,醫療基礎設施的顯著改善,包括能夠支持介入性心臟病器材應用的先進醫療設施的建設,也在促進市場成長。此外,大量強力的臨床證據支持介入性心臟病器材的療效和安全性,也為市場成長提供了動力。

本報告解答的關鍵問題

  • 日本介入性心臟病器材市場目前發展狀況如何?您預計未來幾年該市場將如何發展?
  • 新冠疫情對日本介入性心臟病器材市場產生了哪些影響?
  • 日本介入性心臟病器材市場按產品分類的市場組成是什麼?
  • 日本介入性心臟病器材市場依最終用戶分類的市場區隔如何?
  • 日本介入性心臟病器材市場價值鏈的不同階段有哪些?
  • 日本介入性心臟病器材市場的主要促進因素和挑戰是什麼?
  • 日本介入性心臟病器材市場的結構是怎麼樣的?主要企業有哪些?
  • 日本介入性心臟病器材市場的競爭程度如何?

目錄

第1章:序言

第2章:調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 預測方法

第3章執行摘要

第4章 日本介入性心臟病器材市場-簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本介入性心臟病器材市場概覽

  • 過去和當前的市場趨勢(2020-2025)
  • 市場預測(2026-2034)

6. 日本介入性心臟病器材市場-依產品細分

  • 支架
  • 干涉導管
  • PTCA導管導引線
  • 球囊擴張設備
  • PTCA球囊擴張術

7. 日本介入性心臟病器材市場-依最終用戶細分

  • 醫院
  • 門診手術中心
  • 其他

第8章:日本介入性心臟病器材市場-按地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第9章 日本介入性心臟病器材市場:競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第10章主要企業概況

第11章:日本介入性心臟病器材市場:產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第12章附錄

簡介目錄
Product Code: SR112026A19809

Japan interventional cardiology devices market size reached USD 1.19 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.42 Billion by 2034, exhibiting a growth rate (CAGR) of 8.22% during 2026-2034. The rising prevalence of cardiac ailments, recent advancements in medical technology, introduction of supportive policies, and the growing preference for minimally invasive (MI) procedures over traditional surgeries represent some of the key factors driving the market.

Access the full market insights report Request Sample

Interventional cardiology devices refer to a broad range of specialized tools and equipment utilized in the catheter-based treatment of structural heart diseases. They include stents, catheters, guidewires, balloons, and vascular closure devices, among others. Interventional cardiology devices possess various features, including minimally invasive (MI) nature, precision, flexibility, and advanced technological integration. They are employed in a variety of applications, including angioplasty, stent placement, valvuloplasty, congenital heart defect correction, percutaneous valve repair, and coronary thrombectomy. Interventional cardiology devices aid in improving patient outcomes, reducing recovery times, lowering the risk of infection, minimizing hospital stays, decreasing procedural discomfort, and enhancing diagnostic accuracy. In addition, they are known for their cost-effectiveness in the long term, lower surgical risks, high success rates, and ability to cater to high-risk patients who are not candidates for open-heart surgery.

JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET TRENDS:

The rising prevalence of cardiac ailments in the geriatric population, contributing to the heightened demand for advanced cardiac care, including interventional procedures, is propelling the market growth. Additionally, the increasing prevalence of lifestyle-related diseases, such as hypertension, obesity, and diabetes, which escalates the risk of cardiovascular diseases, is driving the market growth. Besides this, recent advancements in medical technology, leading to the development of more sophisticated and effective interventional cardiology devices, are positively influencing the market growth. Furthermore, the introduction of supportive policies and investments by the government in healthcare infrastructure is bolstering the market growth. In addition, the growing preference for MI procedures over traditional surgeries, owing to their reduced recovery times and lower risks, is catalyzing the market growth. Apart from this, the rising healthcare expenditure, coupled with enhanced insurance coverage for advanced medical procedures, is providing a considerable boost to the market growth. Moreover, the increasing number of specialized cardiologists and healthcare facilities that are equipped to perform interventional cardiology are positively affecting the market growth. Along with this, the growing collaboration and partnerships among leading global and local medical device companies for technology transfer and product development are stimulating the market growth. In addition, the rising awareness about cardiovascular diseases and their treatments among the Japanese population is driving the market growth. Furthermore, the ongoing research and clinical trials aiming to improve the efficacy and safety of interventional cardiology devices are strengthening the market growth. Besides this, the significant improvements in healthcare infrastructure, including the availability of advanced medical facilities that can support the adoption of interventional cardiology devices, are fueling the market growth. Additionally, the widespread availability of strong clinical evidence supporting the effectiveness and safety of interventional cardiology devices is favoring the market growth.

JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Stents Drug Eluting Stents Bare Metal Stents Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Interventional Catheters IVUS Catheters Guiding Catheters Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons Cutting Balloons Scoring Balloons Drug Eluting Balloons Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Stents Drug Eluting Stents Bare Metal Stents Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Interventional Catheters IVUS Catheters Guiding Catheters Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons Cutting Balloons Scoring Balloons Drug Eluting Balloons Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan interventional cardiology devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan interventional cardiology devices market?
  • What is the breakup of the Japan interventional cardiology devices market on the basis of product?
  • What is the breakup of the Japan interventional cardiology devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan interventional cardiology devices market?
  • What are the key driving factors and challenges in the Japan interventional cardiology devices?
  • What is the structure of the Japan interventional cardiology devices market and who are the key players?
  • What is the degree of competition in the Japan interventional cardiology devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Interventional Cardiology Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Interventional Cardiology Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Interventional Cardiology Devices Market - Breakup by Product

  • 6.1 Stents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Drug Eluting Stents
      • 6.1.3.2 Bare Metal Stents
      • 6.1.3.3 Bio-Absorbable Stents
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Interventional Catheters
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 IVUS Catheters
      • 6.2.3.2 Guiding Catheters
      • 6.2.3.3 Angiography Catheters
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 PTCA Guidewires
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Balloon Inflation Device
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 PTCA Balloons
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Segmentation
      • 6.5.3.1 Cutting Balloons
      • 6.5.3.2 Scoring Balloons
      • 6.5.3.3 Drug Eluting Balloons
      • 6.5.3.4 Normal Balloons
    • 6.5.4 Market Forecast (2026-2034)

7 Japan Interventional Cardiology Devices Market - Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Others
    • 7.3.1 Historical and Current Market Trends (2020-2025)
    • 7.3.2 Market Forecast (2026-2034)

8 Japan Interventional Cardiology Devices Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by End User
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by End User
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by End User
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by End User
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by End User
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by End User
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by End User
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by End User
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Interventional Cardiology Devices Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Interventional Cardiology Devices Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix